Navigation Links
The aorta is torn apart in the Marfan syndrome
Date:7/17/2008

A severe complication of the Marfan syndrome is that the aorta may split and be torn apart. The patient can be protected if the syndrome is diagnosed and treated in good time. In the current edition of the Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105[27]: 483-91), the human geneticist Mine Arslan-Kirchner from Hannover University Medical School and his coauthors present additional studies on Marfan patients.

http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60813

Marfan syndrome occurs at a frequency of between 1:5000 and 1:10000 and is either hereditary or the result of spontaneous genetic mutations. As a consequence, there are changes in the consistency of connective tissue. Symptoms develop in the cardiovascular system, the eyes, and the skeleton. A much feared and potentially fatal complication is that the aorta can split and tear. The patient can then die from internal bleeding. Patients' average life expectancy is 32 years without treatment, but can be extended to 60 years with optimal therapy. The full-blown disease is not always present; individual symptoms may be lacking. This makes reliable diagnosis difficult and in many cases, clinical and molecular genetic studies must be combined to clarify the situation. If the diagnosis is made in good time, the damaged aorta can be surgically replaced.


'/>"/>

Contact: Elke Bartholomaeus
bartholomaeus@aerzteblatt.de
49-223-470-11133
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. After more than 100 years apart, webworms devastate New Zealand parsnips
2. Gene regulation, not just genes, is what sets humans apart
3. Researchers discover gene for branchio-oculo-facial syndrome
4. Study suggests new way to screen infants for fetal alcohol syndrome
5. Effective ADHD treatment found for children with fragile X syndrome
6. Rare cancer-causing syndrome found, for the first time, in Singapore
7. Obesity-related hormone is higher in children with Down syndrome
8. Restless legs syndrome affects nearly 2 percent of US/UK children
9. Researchers identify proteins involved in new neurodegenerative syndrome
10. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016   ... management and verification solutions, has partnered with ... software solutions for Visitor Management, Self-Service Kiosks ... provides products that add functional enhancements to ... provides corporations and venues with an automated ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... have just published their findings on what they believe could be a new ... summary of the new research. Click here to read it now. ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: